Macrolide antibiotic compounds
    4.
    发明授权
    Macrolide antibiotic compounds 失效
    麦角抗生素化合物

    公开(公告)号:US5169956A

    公开(公告)日:1992-12-08

    申请号:US543290

    申请日:1990-06-25

    IPC分类号: A01N63/02 C07H19/01 C12P1/06

    摘要: This invention relates to new agents designated LL-F28249.alpha., LL-F28249.beta., LL-F28249.gamma., LL-F28249.delta., LL-F28249.epsilon., LL-F28249.zeta., LL-F28249.eta., LL-F28249.theta., LL-F28249.iota., LL-F28249.kappa., LL-F28249.lambda., LL-F28249.mu., LL-F28249.nu., and LL-F2924.omega., to their production by fermentation, to methods for their recovery and concentration from crude solutions, to processes for their purification and to pharmaceutically and pharmacologically-acceptable salts thereof. The present invention includes within its scope the biologically pure culture which produces there agents, derived from a newly-discovered and previously uncultured microorganism, Streptomyces cyaneogriseus subsp. noncyanogenus, NRRL 15773.

    Biologically pure culture of the microorganism, streptomyces
cyaneogriseus subspecies noncyanogenus, or a mutant thereof
    5.
    发明授权
    Biologically pure culture of the microorganism, streptomyces cyaneogriseus subspecies noncyanogenus, or a mutant thereof 失效
    微生物的生物学纯培养物,非花青素链霉菌亚种,或其突变体

    公开(公告)号:US5418168A

    公开(公告)日:1995-05-23

    申请号:US927581

    申请日:1992-08-10

    摘要: This invention relates to new agents designated LL-F28249.alpha., LL-F28249.beta., LL-F28249.gamma., LL-F28249.delta., LL-F28249.epsilon., LL-F28249.zeta., LL-F28249.eta., LL-F28249.theta., LL-F28249.iota., LL-F28249.kappa., LL-F28249.lambda., LL-F28249.mu., LL-F28249.nu., and LL-F28249.omega., to their production by fermentation, to methods for their recovery and concentration from crude solutions, to processes for their purification and to pharmaceutically and pharmacologically-acceptable salts thereof. The present invention includes within its scope the biologically pure culture which produces there agents, derived from a newly-discovered and previously uncultured microorganism, Streptomyces cyaneogriseus subsp. noncyanogenus, NRRL 15773.

    摘要翻译: 本发明涉及称为LL-F28249α,LL-F28249β,LL-F28249γ,LL-F28249Δ,LL-F28249ε,LL-F28249zeta,LL-F28249 eta,LL-F28249θ,LL-F28249 iota,LL-F28249 kappa,LL-F28249λ,LL-F28249 mu,LL-F28249nu和LL-F28249 omega,通过发酵生产,其从粗溶液中回收和浓缩的方法,以及其纯化方法 以及其药学上和药理上可接受的盐。 本发明在其范围内包括衍生自新发现和先前未培养的微生物Streptomyces cyaneogriseus subsp。的生物纯培养物。 非花青素,NRRL 15773。

    Agents and method of production thereof
    7.
    发明授权
    Agents and method of production thereof 失效
    试剂及其生产方法

    公开(公告)号:US5106994A

    公开(公告)日:1992-04-21

    申请号:US732252

    申请日:1985-05-10

    IPC分类号: A01N63/02 C07H19/01 C12P1/06

    摘要: This invention relates to new agents designated LL-F28249.alpha., LL-F28249.beta., LL-F28249.gamma., LL-F28249.delta., LLF28249.epsilon., LL-F28249.zeta., LL-F28249.eta., LL-F28249.theta., LL-F28249.iota., LL-F28249.kappa., LL-F28249.lambda., LL-F28249.mu., LL-F28249.nu., and LL-F28249.omega., to their production by fermentation, to methods for their recovery and concentration from crude solutions, to processes for their purification and to pharmaceutically and pharmacologically-acceptable salts thereof. The present invention includes within its scope the biologically pure culture which produces there agents, derived from a newly-discovered and previously uncultured microorganism, Streptomyces cyaneogriseus subsp. noncyanogenus, NRRL 15773.

    摘要翻译: 本发明涉及称为LL-F28249α,LL-F28249β,LL-F28249γ,LL-F28249Δ,LLF28249ε,LL-F28249zeta,LL-F28249 eta,LL-F28249θ,LL-F28249Iota, LL-F28249 kappa,LL-F28249 lambda,LL-F28249 mu,LL-F28249 nu和LL-F28249 omega,通过发酵生产,从其回收和从粗溶液中浓缩的方法,其纯化方法和 其药学上可接受的盐。 本发明在其范围内包括衍生自新发现和先前未培养的微生物Streptomyces cyaneogriseus subsp。的生物纯培养物。 非花青素,NRRL 15773。

    Portable Preparation, Analysis, and Detection Apparatus for Nucleic Acid Processing
    8.
    发明申请
    Portable Preparation, Analysis, and Detection Apparatus for Nucleic Acid Processing 审中-公开
    用于核酸加工的便携式制备,分析和检测装置

    公开(公告)号:US20090321259A1

    公开(公告)日:2009-12-31

    申请号:US12433201

    申请日:2009-04-30

    IPC分类号: C12Q1/68 G01N27/447

    摘要: The present teachings comprise a device and method for lysing and/or purifying biological sample. The device can comprise a cartridge having a chamber containing a biological sample receiving region, a plurality of electrodes, and one or more sieving matrices. The electrodes can be configured to lyse the biological sample through the production of a pulsed electrical field. The electrodes can also be configured to heat lyse the biological sample. The electrodes can also be configured to electrophoretically move the biological sample through one or more sieving matrices. A portion of the sample can be isolated on a membrane. The portion of the sample isolated on the membrane can be amplified and detected. A portion of the sample can be isolated in a collection area present in the cartridge. The portion of the sample isolated in the collection area can be removed from the cartridge.

    摘要翻译: 本教导包括用于裂解和/或纯化生物样品的装置和方法。 该装置可以包括具有包含生物样品接收区域,多个电极和一个或多个筛分基质的腔室的药筒。 电极可以被配置成通过产生脉冲电场来裂解生物样品。 电极也可以被配置为热裂解生物样品。 电极还可以被配置成通过一个或多个筛分基质电泳移动生物样品。 样品的一部分可以在膜上分离。 可以扩增和检测在膜上分离的样品的部分。 样品的一部分可以在存在于盒中的收集区域中分离。 分离在收集区域中的样品的部分可以从盒中取出。